Cryoport, Inc. entered an agreement to acquire CRYOPDP, a provider of temperature-controlled logistics solutions to the clinical research, pharmaceutical and cell and gene therapy markets, headquartered in Paris, in a cash transaction valued at approximately €49 million. The acquisition will expand Cryoport’s global supply chain network and services with more than 220 employees located in 22 global facilities in 12 countries. CRYOPDP generated more than €42 million of revenue in 2019. The ac...